Vaccine production
Viability of local vaccine production in developing countries: An economic analysis of cost structures, revenue sizes, market shares and vaccine prices
... to vaccine manufacturers globally (Danzon & Pereira, 2011), making it necessary for manufacturers to find ways to cope with these changes and remain ...local vaccine production context by a ...
212
Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production
... vaccines. At the moment, LPS concentrations are determined by chemical assays or bioassays that do not distinguish different se- rotypes of LPSs. For instance, the WRAIR uses Endosafe-PTS, manufactured by Charles River ...
8
Generation of Synthetic Severe Acute Respiratory Syndrome Coronavirus Pseudoparticles: Implications for Assembly and Vaccine Production
... The generation of viral genome-free SARS-CoV-like parti- cles in this study has implications for vaccine production. The morphology and subcellular location of these VLPs and SARS- CoV are strikingly ...
9
RNA polymerase I driven reverse genetics system for enterovirus 71 and its implications for vaccine production
... Traditionally, potential EV71 vaccine strains are firstly selected from hundreds of clinical isolates which are usually cultured in RD cell. Candidate strains with low virulence and high immunogenicity are then ...
7
Single-Reaction Genomic Amplification Accelerates Sequencing and Vaccine Production for Classical and Swine Origin Human Influenza A Viruses
... The unfolding pandemic of swine origin H1N1 virus dem- onstrates the speed with which influenza A virus can dissemi- nate among our population and illustrates the need for tech- nologies that enable high-throughput ...
5
Modification of glucose import capacity in Escherichia coli: physiologic consequences and utility for improving DNA vaccine production
... values on pDNA production capacity, some of the strains generated in this study were transformed with plasmid pHN. Strains W3110, WG, WGM, WGME, WGMC, WHI and WHIC were transformed with plasmid pHN to generate ...
11
Process development for pandemic influenza VLP vaccine production using a baculovirus expression system
... the production of VLP-based vaccines using the baculovirus expression vector system (BEVS) [11], which provides a rapid and efficient method to generate multiple recombinant proteins for the formation of ...the ...
9
The differentiation and characterization of canine adenoviruses 1 and 2 that are used for vaccine production in the United States
... CAV-1 from CAV-2 through the use of monoclonal antibodies and restriction enzyme analysis; 2 the discovery of a possible method of strain differentiation of CAVs by restriction enzyme an[r] ...
85
Mathematical Models for Influenza Vaccine Production and Distribution.
... Yayla Küllü et al. [ 54 ] studied the effect of resource constraints on product-mix decisions in a multi-product quantity competition. Kluberg and Perakis [ 35 ] analyzed the social surplus and firms’ profits in a ...
102
Vaccine Production Strategies: Ensuring Alignment and Sustainability
... – Recombinant Adenoviral-vectored influenza vaccines – Plant-based manufacturing (subunit versus VLP). – Peptide epitope products (computational vaccinology).[r] ...
25
Design and Development of Modified mRNA Encoding Core Antigen of Hepatitis C Virus: a Possible Application in Vaccine Production
... there are major barriers to widespread use of DAAs regimens, including geographical factors with limited availability of new compounds, virus factors like HCV genotype, host factors such as prolonged liver damage even ...
11
Smallpox Vaccine
... 1983, vaccine production has been halted. Stockpiled vaccine has been used only for laboratory researchers working on ...smallpox vaccine, the adverse effects that were associated with ...
7
PLANT AS A PLATFORM FOR PRODUCTION OF VACCINE
... Bacterial systems for vaccine production cannot produce more complex proteins that folds correctly and undergo forms of post-translational modifications (e.g. N- glycosylation). Furthermore, the presence of ...
7
the vaccine controversy.pdf
... “Our agenda is to protect kids” “I try to stress to my patients that you can’t predict when [vaccine- preventable diseases] are going to show up—and you can’t protect your child any other way,” says Ari Brown, ...
6
A Vaccine for Syphilis
... Over 40 T. Pallidum antigen are available commercially. Including T. pallidum TpN47, T. pallidum major membrane immunogens Tp15, Tp17 and Tp0453. Although antibodies to the variable regions of Treponema pallidum repeat ...
5
BCG VACCINE
... BCG vaccination for all children is a widespread practice in some countries, and it is justified where tuberculosis morbidity and mortality rates are high and where many shortages make u[r] ...
6
POLIOMYELITIS VACCINE
... J onas E. Salk#{176} and his collaborators in de- veloping the vaccine and studying its effects in respect to antigenicity and safety, some of which was published in IA7.. Certain featur[r] ...
6
Introduction of Inactivated Polio Vaccine and Specific Determinants of Vaccine Hesitancy
... Most of the responses given by the parents were pro-vaccine hesitancy, but majority still accepted to vacci- nate their children. This highlights the lack of connection between their understanding of various ...
12
CURRENT VACCINE
... NEW VACCINE Implementation of routine immunization with the new conjugate pneumococcal vaccine could lead to a significant reduction in morbidity from S pneumoniae bacteremia and meningitis as well as from ...
5
DESIGNING A VACCINE FOR CANCER: A LOOK INTO DENDRITIC CELL CANCER VACCINE:
... The fundamental premise behind clinical approaches for dendritic cell-mediated immunization in cancer is that the limiting defect in natural antitumor immunity is at the level of antigen presentation. In contrast to ...
5